摘要 |
Disclosed are benztropinamine analogs having the formula I (I) in which E is NR<SUP>1</SUP>, S, or CH<SUB>2</SUB>; B is NR<SUP>4</SUP>, O, or CH<SUB>2</SUB>; m=1 to 5; n=1 to 3; Ar is a C<SUB>5</SUB>-C<SUB>20 </SUB>monocyclic aryl group or a C<SUB>10</SUB>-C<SUB>20 </SUB>bicyclic aryl group or a heteroaryl group having 2 to 6 carbon atoms and one or more heteroatoms selected from the group consisting of N, O, S, and any combination thereof; and bond "a" can be of alpha, beta, or alpha/beta configuration, wherein R<SUP>1 </SUP>to R<SUP>5 </SUP>are as described in the specification; or a pharmaceutically acceptable salt or solvate thereof; pharmaceutical compositions and use thereof, e.g., in treating mental disorders.
|